Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The boundlessness of behavioral neuroscience: A look across 30 years.

Neuroscience and biobehavioral reviews·2022
Same author

Semen quality and infertility status can be identified through measures of oxidation-reduction potential.

Andrologia·2017
Same author

Susceptibility to a parkinsonian toxin varies during primate development.

Experimental neurology·2012
Same author

Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease.

Neuroscience·2011
Same author

Aged monkeys as a partial model for Parkinson's disease.

Pharmacology, biochemistry, and behavior·2011
Same author

Age-dependent neurobehavioral responses by young and mature adult rats to systemic kainic acid.

Restorative neurology and neuroscience·2011

Related Experiment Video

Updated: Jul 4, 2026

Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells
08:35

Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells

Published on: August 24, 2018

Biocompatibility of PEG-based hydrogels in primate brain.

K B Bjugstad1, D E Redmond, K J Lampe

  • 1Department Pediatrics, University Colorado Denver and Health Sciences Center, Aurora, CO 80045, USA. kimberly.bjugstad@uchsc.edu

Cell Transplantation
|June 5, 2008
PubMed
Summary

Polyethylene glycol (PEG)-based hydrogels show potential for brain applications. Studies in nonhuman primates indicate minimal immune response, suggesting suitability for neural tissue regeneration and drug delivery.

More Related Videos

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke
09:41

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke

Published on: October 1, 2020

Microwave-assisted Functionalization of Poly(ethylene glycol) and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
15:33

Microwave-assisted Functionalization of Poly(ethylene glycol) and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation

Published on: October 29, 2013

Related Experiment Videos

Last Updated: Jul 4, 2026

Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells
08:35

Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells

Published on: August 24, 2018

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke
09:41

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke

Published on: October 1, 2020

Microwave-assisted Functionalization of Poly(ethylene glycol) and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
15:33

Microwave-assisted Functionalization of Poly(ethylene glycol) and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation

Published on: October 29, 2013

Area of Science:

  • Biomaterials Science
  • Neuroscience
  • Immunology

Background:

  • Degradable polymers are widely used in peripheral tissue regeneration and drug delivery.
  • The brain's unique immune environment poses challenges for biomaterial compatibility.
  • Polyethylene glycol (PEG)-based hydrogels are being explored for neural applications.

Purpose of the Study:

  • To evaluate the biocompatibility of PEG-based hydrogels in the nonhuman primate brain.
  • To assess the host immune response to implanted hydrogels over four months.
  • To determine the potential of PEG hydrogels for neural tissue reconstruction and drug delivery.

Main Methods:

  • PEG-based hydrogels (20% w/v) were implanted into the striatum and cerebral cortex of nonhuman primates.
  • Brain tissue was analyzed after four months for astrogliosis, scarring, microglia/macrophage presence, and T-cell infiltration.
  • Immunohistochemistry was used to quantify glial fibrillary acidic protein (GFAP), CD68, and CD3+ T cells.

Main Results:

  • A slight, non-significant increase in astrocytic (GFAP) and microglial/macrophage (CD68) markers was observed compared to sham implants.
  • No significant gliotic scarring or peripheral T-cell (CD3+) infiltration was detected.
  • The immune response was comparable to the brain's natural state, indicating good tolerance.

Conclusions:

  • PEG-based hydrogels demonstrate a low level of immune response in the primate brain.
  • The observed response does not indicate immunorejection, suggesting good biocompatibility.
  • PEG hydrogels hold promise for future applications in primate brain drug delivery and neural tissue regeneration.